Dr Reddy’s, Torrent Pharma, Zydus Life: Pharma stocks to post resilient growth in Q2 earnings despite pricing headwinds
Q2 results preview: Pharma companies are likely to gain from the domestic market demand for healthcare amid the weak cues for the exports business to the United States.
Q2 results preview: Pharma companies are likely to gain from the domestic market demand for healthcare amid the weak cues for the exports business to the United States.
What's Your Reaction?
